問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2008-10-01 - 2010-10-31
Condition/Disease
Test Drug
Participate Sites3Sites
Terminated3Sites
2007-08-01 - 2009-08-30
Participate Sites5Sites
Terminated5Sites
2007-08-01 - 2008-12-31
Participate Sites9Sites
Terminated9Sites
2023-10-01 - 2030-12-31
Biliary Tract Cancer
Rilvegostomig
Participate Sites8Sites
Recruiting8Sites
2023-02-15 - 2025-06-30
Chronic Hepatitis B
GS-2829GS-6779
Participate Sites10Sites
Recruiting10Sites
2024-01-01 - 2027-12-31
Recruiting5Sites
2018-06-01 - 2023-12-31
Primary Myelofibrosis (PMF) or Post-Polycythemia Vera or Post- Essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)
Momelotinib Film-coated Tablets
Participate Sites4Sites
Recruiting3Sites
Terminated1Sites
全部
